✦ LIBER ✦

Cisplatin-docetaxel (Taxotere®) in first line treatment of advanced ovarian cancer (AOC)

✍ Scribed by V. Dieras; J.M. Ferrero; R. Kheder; B. Weber; P. Winckel; A. Lortho-lary; F. Mayer; D.J. Paraiso; E. Pujade-Lauraine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of cisplati

✍ Véronique Diéras; JeanPaul Guastalla; JeanMarc Ferrero; Hervé Curé; Béatrice Web 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

520 First-line chemotherapy with carbopl

✍ D.Z. Edelmann; T. Peretz; V. Barak; S.O. Anteby 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase II trials of docetaxel (taxotere®)

✍ S.B. Kaye; M. Piccart; M. Aapro; P. Francis; J. Kavanagh 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 457 KB

542 - Treatment of advanced ovarian canc

✍ J. Casal; M. Caelro; A. de la Orden; C. Grande; C. Obispo; G. Bravo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 255 KB

First line combination chemotherapy with

✍ Athanassiou, AE; Bafaloukos, D; Pectasides, D; Dimitriadis, M; Varthalitis, I; B 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 618 KB

Docetaxel plus carboplatin shows promise

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB